Table 2.
Cumulative Incidence of Death by Race and Ethnicity From the 2000 to 2018 SEER 18 Registries Database
| Populationa | Cumulative Incidence of Death (95% CI)b |
||||
|---|---|---|---|---|---|
| 2 Years (%) | 5 Years (%) | 10 Years (%) | 18 Years (%) | ||
| All-cause mortality | |||||
| NH White | 1,235,934 (45.7) | 23.9 (23.9-24.0) | 34.8 (34.7-34.9) | 47.8 (47.7-47.9) | 65.6 (65.5-65.7) |
| NH Black | 195,586 (48.5) | 27.1 (27-27.3) | 39.2 (39.1-39.4) | 52.3 (52.1-52.5) | 69.5 (60.2-69.9) |
| Hispanic | 120,757 (36.6) | 19.6 (19.5-19.8) | 29.9 (29.7-30.1) | 42 (41.8-42.2) | 59.6 (59.2-60.0) |
| NH Asian/Pacific Islander | 85,264 (38.0) | 21.1 (21-21.3) | 31.5 (31.3-31.7) | 42.4 (42.1-42.6) | 58.5 (58.1-59.0) |
| NH American Indian/Alaska Native | 6,526 (45.5) | 25.2 (24.5-26) | 37.1 (36.2-37.9) | 50.2 (49.2-51.1) | 68.8 (66.9-70.6) |
| CVD mortality | |||||
| NH White | 180,069 (6.7) | 1.9 (1.9-1.9) | 3.8 (3.8-3.9) | 7.4 (7.4-7.4) | 14.2 (14.1-14.3) |
| NH Black | 27,090 (6.7) | 2.2 (2.2-2.3) | 4.3 (4.2-4.3) | 7.9 (7.8-8) | 14.6 (14.3-14.8) |
| Hispanic | 13,822 (4.2) | 1.2 (1.2-1.3) | 2.6 (2.5-2.6) | 5.2 (5.1-5.3) | 10.9 (10.6-11.2) |
| NH Asian/Pacific Islander | 9,711 (4.3) | 1.4 (1.3-1.4) | 2.6 (2.6-2.7) | 5.1 (4.9-5.2) | 10.5 (10.2-10.8) |
| NH American Indian/Alaska Native | 694 (4.8) | 1.5 (1.3-1.7) | 3.1 (2.8-3.4) | 5.9 (5.4-6.4) | 12.5 (10.9-14.2) |
| Cancer mortality | |||||
| NH White | 746,315 (27.6) | 19.5 (19.5-19.6) | 25.7 (25.6-25.7) | 30.3 (30.2-30.3) | 34.6 (34.5-34.7) |
| NH Black | 125,845 (31.2) | 22.1 (22.0-22.3) | 29.7 (29.5-29.8) | 34.9 (34.7-35.1) | 40.0 (39.7-40.2) |
| Hispanic | 77,802 (23.6) | 16.0 (15.9-16.2) | 22.6 (22.5-22.8) | 27.9 (27.7-28.0) | 32.8 (32.5-33.1) |
| NH Asian/Pacific Islander | 57,260 (25.5) | 17.6 (17.4-17.7) | 24.6 (24.4-24.8) | 29.3 (29.1-29.5) | 33.4 (33.1-33.7) |
| NH American Indian/Alaska Native | 4,288 (29.9) | 21.0 (20.3-21.7) | 28.6 (27.8-29.4) | 33.9 (33.0-34.8) | 39.5 (38.0-41.0) |
Values are n (%), unless otherwise indicated.
CVD = cardiovascular disease; other abbreviations as in Table 1.
a
Crude number and rate estimates of mortality from the 2000-2018 SEER data.
b
All-cause mortality estimated by Kaplan-Meier methods; CVD and cancer mortality estimated by Fine and Gray’s competing risk method.